| (USD) | Mar 2009 | Y/Y change |
|---|---|---|
| Revenue | 3.01M | — |
| Operating expense | — | — |
| Net income | 0.00 | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, NTII returned +0.0% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +0.0% |
| 1 year | +0.0% |
| 5 years | -33.3% |
| 10 years | -99.5% |
| All-time high | $59.50 (Jun 2000) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in NTII would be worth today ›No. Neurobiological Technologies, Inc. has not paid a dividend in the past 12 months.
Neurobiological Technologies, Inc. is part of the Healthcare sector.
Neurobiological Technologies, Inc. has a market cap of 2.70K USD, based on the latest quote.